19 results on '"Patel, Jaymala"'
Search Results
2. Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study
3. Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in MajesTEC-1
4. Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide
5. Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC)
6. Biomarker Correlates of Response to Ciltacabtagene Autoleucel in Patients with Relapsed or Refractory Multiple Myeloma from CARTITUDE-1, a Phase 1b/2 Open-Label Study, at the ~3 Year Follow-up
7. Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice
8. Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide
9. Prediction of metastatic castrate-resistant prostate cancer response to abiraterone or enzalutamide by a baseline blood-based CTC gene expression signature.
10. Abstract 2959: Analysis of circulating tumor DNA reveals genomic alterations in metastatic prostate cancer patients treated with abiraterone acetate plus prednisone or enzalutamide
11. Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide
12. Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC)
13. Abstract 2755: Comparison of blood based liquid biopsy methodologies for improved risk assessment of prostate cancer (PCa)
14. Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide
15. Abstract 3063: Molecular characterization of individual circulating tumor cells by RNA sequencing
16. Development and analysis of androgen receptor (AR) axis biomarkers of circulating tumor cells (CTCs) in Japanese metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA).
17. Abstract 1443: Improved molecular characterization of circulating tumor cells.
18. Automated Enumeration and Characterization of Circulating Multiple Myeloma Cells in Blood
19. Validation of the Cylex Technology to Measure T and B Cell Activation Capacity in Clinical Trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.